Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I (+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia

Leukemia Research

Volumn 23, Issue 4, 1999, Pages 373-384

  Zhang, Qian ^a   Lee, Benhur ^a   Korecka, Magda ^a   Li, Gong ^a   Weyland, Charles ^a   Eck, Steven ^a   Gessain, Antoine ^b   Arima, Naochimi ^c   Lessin, Stuart R ^a   Shaw, Leslie M ^a   Luger, Selina ^a   Kamoun, Malek ^a   Wasik, Mariusz A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INSTITUT PASTEUR   (France)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

IL 2R signaling; JAK5 kinase; Malignant T cells; SHP 1 phosphatase; STAT 5 protein

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; PROTEIN TYROSINE KINASE; RAPAMYCIN; RECOMBINANT INTERLEUKIN 2; STAT3 PROTEIN; STAT5 PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; MALIGNANT TRANSFORMATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 0032895421     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00173-8     Document Type: Article

References (71)

1. Nelson B.H., Lord J.D., Greenberg P.D. Cytoplasmic domains of the interleukin-2 receptor β and α chains mediate the signal for T-cell proliferation. Nature. 369:1994;333-336.
2. Leonard W.J., Noguchi M., Russell S.M., McBride O.W. The molecular basis of X linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common γ chain, γ c. Immunol. Rev. 138:1994;61-86.
3. Noguchi M., Nakamura Y., Russell S.M., Ziegler S.F., Tsang M., Cao X., Leonard W.J. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science. 262:1993;1877-1880.
4. Tagaya Y., Bamford R.N., DeFilippis A.P., Waldman T.A. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity. 4:1996;329-336.
5. Taniguchi T. Cytokine signalling through nonreceptor protein tyrosine kineses. Science. 268:1995;251-255.
6. Leonard W.J., O'Shea J.J. JAKS AND STATS: biological implications. Ann. Rev. Immunol. 16:1998;293-322.
7. Witthuhn B.A., Silvennoinen O., Miura O., Lai K.S., Cwik C., Liu E.T., Ihle J.N. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature. 370:1994;153-157.
8. Lin J.-X., Migone T.-S., Tsang M., Friedman M., Weatherbee J.A., Zhou L., Yamauchi A., Bloom E.T., Mietz J., John S., Leonard W.J. The role of shared receptor motifs and common STAT proteins in the generation of cytokine pleiotrophy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity. 2:1995;331-339.
9. Beadling C., Guschin D., Witthuhn B.A., Ziemiecki A., Ihle J.N., Kerr I.M., Cantrell D.A. Activation of JAK kineses and STAT proteins by interleukin-2 and interferon-γ, but not the T-cell antigen receptor, in human T lymphocytes. Embo. J. 13:1994;5605-5615.
10. Nielsen M., Svejgaard A., Skov S., Odum N. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of STAT3 in human T lymphocytes. Eur. J. Immunol. 24:1994;3082-3086.
11. Macchi P, Villa A, Gillani S, Sacco MG, Frattini A, Porta, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, Vezzoni P, Notarangelo LD. Mutations of Jak-3 gene in patients with autosomal severe combined immune defiency (SCID). Nature 1995;377:65-68.
12. Russell S.M., Tayebi N., Nakajima H., Riedy M.C., Roberts J.L., Aman M.J., Migone T.S., Noguchi M., Markert M.L., Buckley R.H., O'Shea J.J., Leonard W.J. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science. 270:1995;797-800.
13. Nosaka T., van Deursen J.M., Tripp R.A., Thierfelder W.E., Witthuhn B.A., McMickle A.P., Dohrty P.C., Grosveld G.C., Ihle J.N. Defective lymphoid development in mice lacking Jak3. Science. 270:1995;800-802.
14. Thomis D.C., Gurniak C.B., Tivol E., Sharpe A.H., Berg L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science. 270:1995;794-797.
15. Noguchi M., Yi H., Rosenblatt H.M., Filipovich A.H., Adelstein S., Modi W.S., McBride O.W., Leonard W.J. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 73:1993;147-157.
16. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M. et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity. 2:1995;223-238.
17. DiSanto J.P., Muller W., Guy-Grand D., Fischer A., Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc. Natl. Acad. Sci. USA. 92:1995;377-381.
18. Ohbo K, Suda T, Hashiyama M, Mantani A, Ikebe M, Miyakawa K, Moriyama M, Nakamura M, Katsuki M, Takahashi K, Yamamura K, Sugamura K. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor chain. Blood 1996; 956-967.
19. Bunting K.D., Sangster M.Y., Ihle J.N., Sorrentino B.P. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nature. Med. 4:1998;58-64.
20. Sohn S.J., Forbush K.A., Nguyen N., Witthuhn B., Nosaka T., Ihle J.N., Perlmutter R.M. Requirement for Jak3 in mature T-cells: its role in regulation of T-cell homeostasis. J. Immunol. 160:1998;2130-2138.
21. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D.M., Brown M., Bodner S., Grosveld G., Ihle J.N. Stat5a and STAT5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 93:1998;841-850.
22. Yamaguchi K., Takatsuki K. Adult T-cell leukemia-lymphoma. Clin. Haematol. 6:1993;899-915.
23. Hollsberg P., Hafler D.A. Pathogenesis of diseases induced by human lymphotrophic virus type I infection. New Eng. J. Med. 328:1993;1173-1182.
24. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br. J. Haematol. 79:1991;428-437.
25. Yoshida M., Seiki M., Yamaguchi K., Takatsuki K. Monoclonal integration of HTLV in all primary tumors of adult T-cell leukemia suggests causative role of HTLV in the disease. Proc. Natl. Acad. Sci. USA. 81:1984;2534-2537.
26. Chen Y.A., Essex M. Antibody responses to different regions of HTLV-I gp61 in asymptomatic carriers, ATL patients, and individuals with TSP. Blattner W.A. Human Retroviruses:HTLV. 1990;447-460 Raven Press, New Haven.
27. Yamaguchi K., Kiyokawa T., Nakada K. Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL. Br. J. Haematol. 68:1988;169-174.
28. Tokudome S., Tokunaga O., Shimamoto Y. Incidence of adult T-cell leukemiallymphoma among human T-lymphotrophic virus type I carrier in Saga, Japan. Cancer Res. 49:1989;226-228.
29. Migone T.S., Lin J.X., Cereseto A., Mulloy J.C., O'Shea J.J., Franchini G., Leonard X.W.J. Constitutively activated Jak-STAT pathway in T-cells transformed with HTLV I. Science. 269:1995;79-81.
30. Xu X., Kang S.-H., Heidenreich O., Okerholm M., O'Shea J.J., Nerenberg M.I. Constitutive activation of different Jak tyrosine kineses in human T-cell leukemia. virus type 1 (HTLV-1) Tax protein or virus-transformed cells. J. Clin. Invest. 96:1995;1548-1555.
31. Zhang Q., Nowak I., Vonderheid E.C., Rook A.H., Kadin M.E., Nowell P.C., Shaw L.M., Wasik M.A. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc. Natl. Acad. Sci. USA. 93:1996;9148-9153.
32. Wasik M.A., Morimoto C. Differential effects of cytokines on proliferative response of human CD4+ T-cell subsets stimulated via CD3-TCR complex. J. Immunol. 144:1990;3334-3338.
33. Kamihira S., Atogami S., Sohda H., Momita S., Yamada Y., Tomonaga M. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer. 73:1994;2753-2758.
34. Srivastava M.D., Srivastava A., Srivastava B.I. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies. Leuk. Lymphoma. 12:1994;241-251.
35. Wasik M.A., Vonderheid E.C., Bigler R.D., Marti R., Lessin S., Polansky M., Kadin M.E. Increased serum concentration of of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma clinical and prognostic implications. Arch. Dermatol. 132:1996;42-47.
36. Maeda M., Shimuzu A., Ikuta K., Okamoto H., Kashihara M., Uchiyama T., Honjo T., Yodoi J. Origin of human T-lymphotrophic virus I-positive T-cell lines in adult. T-cell leukemia. Analysis of T-cell receptor gene rearrangement. J. Exp. Med. 162:1985;2169-2174.
37. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and humna leukaemic T-cells. Nature. 294:1981;770-771.
38. Popovic M., Sarin P.S., Robert-Gurnoff M., Kalyanaraman V.S., Mann D., Minowada J., Gallo R.C. Isolation and transmission of human retrovirus (human T-cell leukemia virus). Science. 219:1983;856-859.
39. Poiescz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:1980;7415-7419.
40. Bunn PA Jr., Foss FM. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL). J Cell Biochem 1996-Suppl 24: 12-23.
41. Gessain A., Saal F., Giron M.-L., Lasnaret J., Lagaye S., Gout O., De The G., Sigoux F., Peries J. Cell surface phenotype and human T lymphotropic virus type I antigen expression in 12 T-cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis. J. Gen. Virol. 71:1990;333-341.
42. Abrams J.T., Lessin S., Ghosh S.K., Ju W., Vonderheid E.C., Nowell P., Murphy G., Elfenbein B., DeFreitas E. A donal CD4-positive T-cell line established from the blood of a patient with Sezary Syndrome. J. Invest. Dermatol. 96:1991;31-37.
43. Yodoi J., Teshigawara K. TCGF (IL-2)-receptor inducing factor(s). I. Regulation of 11-2 receptor on a natural killer-like cell line (YT cells). J. Immuonol. 134:1985;1623-1630.
44. Wasik M.A., Seldin D.C., Butmarc J.R., Gertz R., Marti R., Maslinski W., Kadin M.E. Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder. Leuk. Lymphoma. 23:1996;125-136.
45. Marti R., Wasik M.A., Kadin M.E. Constitutive and selective secretion of GM CSF by three different cell lines derived from a single patient with a progressive cutaneous lymphoproliferative disorder. Cytokine. 8:1996;323-329.
46. Kwok S., Kellogg D., Ehrlich G., Poiescz B., Bhagavati S., Sninsky J.J. Characterization of a sequence of human T-cell leukemia virus type I from a patient with chronic progressive myelopathy. J. Inf. Dis. 158:1988;1193-1197.
47. Lessin S.R., Rook A.H., Rovera G. Molecular diagnosis of cutaneous T-cell lymphoma polymerase chain amplification of T-cell antigen receptor β-gene rearrangements. J. Invest. Dermatol. 96:1991;299-302.
48. Wasik M.A., Nowak I., Zhang Q., Shaw L.M. Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine. Leuk. Lymphoma. 28:1998;551-560.
49. Migone T.S., Calacano N.A. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T lymphotropic virus type I-transformed T-cells. Proc. Natl. Acad. Sci. USA. 95:1998;3845-3850.
50. Klingmuller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of SH-PTP1 to the erythropooietin receptor causes inactivation of Jak2 and terminaation of proliferative signals. Cell. 80:1995;729.
51. Shultz L.D., Schweitzer P.A., Rajan T.V., Yi T., Ihle J.N., Matthews R.J., Thomas M.L., Beier D.R. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 73:1993;1445.
52. Shultz L.D., Rajan T.V., Greiner D.L. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends. Biotechnol. 15:1997;302.
53. Chung J, Grammer TC, Lemon KP, Kazlauskas A, Blenis J. PDGF- and insulin-dependent pp70S6K activation mediated by phosphatidylinositol-3-OH kinase. Nature 1994;370-1.
54. Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, Schreiber SL. Control of p70S6 kinase by kinase activity of FRAP in vivo. Nature 1995;377-441.
55. Takemoto S., Mulloy J.C., Cereseto A., Migone T.S., Patel B.K.R., Matsuoka M. et al. Proliferation of adult T-cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl. Acad. Sci. USA. 94:1997;13897-13902.
56. Arima N. Autonomous and interleukin-2-responsive growth of leukemic cells in adult T-cell leukemia (ATL): a review of the clinical signifcance and molecular basis of ATL cell growth. Leuk. Lymphoma. 26:1997;479-489.
57. Lal R.B., Rudolph D.L., Folks T.M., Hooper W.C. Over expression of insulin-like growth factor receptor type-1 in T-cell lines infected with human T-lymphotropic virus types-I and-II. Leukemia Res. 17:1993;31-35.
58. Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood 1996;88:1035-45.
59. Ratajczak M.Z., Marlicz W., Ratajczak J., Machalinski B., Wasik M.A., Carter A., Gewirtz A.M. Effect of hepatocyte growth factor (HGF) on early human hematopoietic cell development. Brit. J. Haematol. 99:1997;228-236.
60. Koochekpour S., Jeffers M., Rulong S., Taylor G., Klineberg E., Hudson E.A., Resau J.H., Vande Woude G.F. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer. Res. 57:1997;5391-5398.
61. Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida T, Zbar B, Vande Woude GF. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 1997;94:11445-50.
62. Schmidt L., Junker K., Weirich G., Glenn G., Choyke P., Lubensky I., Zhuang Z., Jeffers M., Vande Woude G., Neumann H., Walther M., Linehan W.M., Zbar B. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res. 58:1998;1719-1722.
63. Finbloom D.S., Winestock K.D. IL-10 induces the tyrosine phosphorylation of tyk2 and Jakl and the differential assembly of STAT 1 α and STAT3 complexes in human T-cells and monocytes. J. Immunol. 155:1995;1079-1090.
64. Hatta Y., Hirama T., Miller C.W., Yamada Y., Tomonaga M., Koeffler H.P. Homozygous deletions of the p15 (MTS2) and pl6 (CDKN2/MTS 1) genes in adult T-cell leukemia. Blood. 85:1995;2699-2704.
65. Ogawa S., Hangaishi A., Miyawaki S., Hirosawa S., Miura Y., Takeyama K. et al. Loss of the cyclin-dependent kinase 4-inhibitor (p16;MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood. 86:1995;1548-1556.
66. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gpl30. Blood. 86:1995;1243-1254.
67. Fujii H., Nakagawa Y., Schindler U., Kawahara A., Mori H., Gouilleux F., Groner B., Ihle J.N., Minami Y., Miyazaki T., Taniguchi T. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. USA. 92:1995;5482-5486.
68. Ahmed N.N., Grimes H.L., Bellacosa A., Chan T.O., Tsichlis P.N. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA. 94:1997;3627-3632.
69. Takeshita T., Arita T., Asao H., Tanaka N., Higuchi M., Kuroda H., Kaneko K., Munakata H., Endo Y., Fujita T., Sugamura K. Cloning of a novel signaltransducing adapter molecule containing an SH3 domain and ITAM. Biochem. Biophys. Res. Comm. 225:1996;1035-1041.
70. Takeshita T., Arita T., Higuchi M., Asao H., Endo K., Kuroda H., Tanaka N., Murata K., Ishii N., Sugamura K. STAM, signal transducing adaptor molecule, is associated with Janus kineses and involved in signaling for cell growth and c-myc induction. Immunity. 6:1997;449-457.
71. Miyazaki T., Takaoka A., Nogueira L., Dikic I., Fujii H., Tsujino S., Mitani Y., Maeda M., Schlessinger J., Taniguchi T. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev. 12:1998;770-775.